---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-003966"
form_type: "8-K"
ticker: "STIM"
cik: "0001227636"
company_name: "Neuronetics, Inc."
filed_at: "2024-01-08T23:59:59+00:00"
generated_at: "2026-06-07T02:01:31.771700+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Neuronetics reports preliminary Q4 revenue over $20M, record treatment session revenue

## Summary
- Preliminary Q4 2023 total revenue >$20M (guidance $19-21M); U.S. NeuroStar system revenue ~$4.5M on 59 system shipments.
- U.S. Treatment Session revenue >$14.5M (company record, +20% YoY); local consumable revenue +33% YoY.
- Generated positive cash flow >$1M in Q4; ended 2023 with cash and equivalents ~$59M.
- Full year 2023 preliminary revenue >$71M (guidance $70-72M); momentum cited across key customer segments.
- Next phase of Better Me Guarantee Provider pilot to launch Jan 22, 2024 with ~100 sites; over 275 sites eligible later in 2024.

## SEC filing metadata
- accession: 0001193125-24-003966
- form_type: 8-K
- ticker: STIM
- cik: 0001227636
- company_name: Neuronetics, Inc.
- filed_at: 2024-01-08T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1227636/000119312524003966/0001193125-24-003966-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1227636/000119312524003966/d291263d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-003966
- JSON: https://secwatch.observer/filing/0001193125-24-003966.json
- Plain text: https://secwatch.observer/filing/0001193125-24-003966.txt

## Key facts
- Earnings Releases
  Neuronetics, Inc. reported the three months ended December 31, 2023 results: revenue over $20 million.
  - Period: the three months ended December 31, 2023
  - Revenue: over $20 million
  - Result: preliminary results
  source text: Preliminary unaudited total revenue is expected to be over $20 million as compared to previously stated guidance of $19.0 to $21.0 million.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1227636/000119312524003966/0001193125-24-003966-index.htm
- Earnings Releases
  Neuronetics, Inc. reported the twelve months ended December 31, 2023 results: revenue over $71 million.
  - Period: the twelve months ended December 31, 2023
  - Revenue: over $71 million
  - Result: preliminary results
  source text: Preliminary unaudited total revenue is expected to be over $71 million as compared to previously stated guidance of $70.0 to $72.0 million.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1227636/000119312524003966/0001193125-24-003966-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.